Literature DB >> 16269551

Effect of a beta-lapachone-derived naphthoimidazole on Trypanosoma cruzi: identification of target organelles.

Rubem F S Menna-Barreto1, Andrea Henriques-Pons, Antônio V Pinto, José A Morgado-Diaz, Maurilio J Soares, Solange L De Castro.   

Abstract

OBJECTIVES: Investigation of the mode of action of the naphthoimidazole N1, obtained from the reaction of beta-lapachone with benzaldehyde, which among 45 semi-synthetic derivatives of naphthoquinones isolated from Tabebuia sp. was one of the most active compounds against Trypanosoma cruzi trypomastigotes.
METHODS: Quantification of the effect of N1 against the proliferative forms of T. cruzi, and investigation of potential targets in the parasite using electron microscopy and flow cytometry techniques.
RESULTS: N1 presented the following order of activity: amastigotes > trypomastigotes > epimastigotes. The effect on intracellular forms was approximately 25 times higher than on macrophages and heart muscle cells. N1-treated parasites presented an abnormal chromatin condensation and mitochondrial damage. In epimastigotes, alterations of reservosomes were observed, and in trypomastigotes, a decrease in the electron density of acidocalcisomes was observed. In epimastigotes, the naphthoimidazole inhibited the activity of succinate cytochrome c reductase. Labelling with rhodamine 123 or Acridine Orange was decreased in both forms treated with N1.
CONCLUSIONS: The results suggest that epimastigotes, reservosomes, mitochondrion, and nucleus contain N1 targets. In trypomastigotes, in which reservosomes are absent, the organelles affected by the compound were also the mitochondrion and nucleus, as well as acidocalcisomes, in which the decrease in electron density could be due to the use of polyphosphate as an alternative energy supply.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16269551     DOI: 10.1093/jac/dki403

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.758


  29 in total

1.  Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment.

Authors:  Denise da Gama Jaén Batista; Marcos Meuser Batista; Gabriel Melo de Oliveira; Patrícia Borges do Amaral; Joseli Lannes-Vieira; Constança Carvalho Britto; Angela Junqueira; Marli Maria Lima; Alvaro José Romanha; Policarpo Ademar Sales Junior; Chad E Stephens; David W Boykin; Maria de Nazaré Correia Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

Review 2.  Mitochondria and trypanosomatids: targets and drugs.

Authors:  Lianet Monzote Fidalgo; Lars Gille
Journal:  Pharm Res       Date:  2011-09-21       Impact factor: 4.200

Review 3.  Autophagy in protists.

Authors:  Michael Duszenko; Michael L Ginger; Ana Brennand; Melisa Gualdrón-López; María Isabel Colombo; Graham H Coombs; Isabelle Coppens; Bamini Jayabalasingham; Gordon Langsley; Solange Lisboa de Castro; Rubem Menna-Barreto; Jeremy C Mottram; Miguel Navarro; Daniel J Rigden; Patricia S Romano; Veronika Stoka; Boris Turk; Paul A M Michels
Journal:  Autophagy       Date:  2011-02-01       Impact factor: 16.016

4.  Mitochondrial disruption and DNA fragmentation in Trypanosoma cruzi induced by naphthoimidazoles synthesized from beta-lapachone.

Authors:  R F S Menna-Barreto; J R Corrêa; A V Pinto; M J Soares; S L de Castro
Journal:  Parasitol Res       Date:  2007-06-02       Impact factor: 2.289

5.  Anti-Trypanosoma cruzi activity of Pterodon pubescens seed oil: geranylgeraniol as the major bioactive component.

Authors:  R F S Menna-Barreto; G A T Laranja; M C C Silva; M G P Coelho; M C Paes; M M Oliveira; S L de Castro
Journal:  Parasitol Res       Date:  2008-06       Impact factor: 2.289

6.  Epoxy-α-lapachone has in vitro and in vivo anti-leishmania (Leishmania) amazonensis effects and inhibits serine proteinase activity in this parasite.

Authors:  Franklin Souza-Silva; Saulo Cabral Bourguignon; Bernardo Acácio Santini Pereira; Luzia Monteiro de Castro Côrtes; Luiz Filipe Gonçalves de Oliveira; Andrea Henriques-Pons; Lea Cysne Finkelstein; Vitor Francisco Ferreira; Paula Fernandes Carneiro; Rosa Teixeira de Pinho; Ernesto Raul Caffarena; Carlos Roberto Alves
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

7.  Ultrastructural alterations induced by the neolignan dihydrobenzofuranic eupomatenoid-5 on epimastigote and amastigote forms of Trypanosoma cruzi.

Authors:  Patrícia Shima Luize; Tânia Ueda-Nakamura; Benedito Prado Dias Filho; Diógenes Aparício Garcia Cortez; José Andrés Morgado-Díaz; Wanderley de Souza; Celso Vataru Nakamura
Journal:  Parasitol Res       Date:  2006-06-17       Impact factor: 2.289

8.  3-Hydroxykynurenine, a Tryptophan Metabolite Generated during the Infection, Is Active Against Trypanosoma cruzi.

Authors:  Carolina P Knubel; Constanza Insfran; Fernando F Martinez; Cintia Diaz Lujan; Ricardo E Fretes; Martin G Theumer; Laura Cervi; Claudia C Motran
Journal:  ACS Med Chem Lett       Date:  2017-06-12       Impact factor: 4.345

Review 9.  The acidocalcisome as a target for chemotherapeutic agents in protozoan parasites.

Authors:  Roberto Docampo; Silvia N J Moreno
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

10.  Benzaldehyde thiosemicarbazone derived from limonene complexed with copper induced mitochondrial dysfunction in Leishmania amazonensis.

Authors:  Elizandra Aparecida Britta; Ana Paula Barbosa Silva; Tânia Ueda-Nakamura; Benedito Prado Dias-Filho; Cleuza Conceição Silva; Rosana Lázara Sernaglia; Celso Vataru Nakamura
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.